Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults

다국어 초록 (Multilingual Abstract)

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of defective apoptosis, a disruption of the regulatory pathway that terminates immune and inflammatory responses.
Fever, cytopenia, splenomegaly, and/or hemophagocytosis are typical findings of this syndrome. HLH can be induced by genetic disorders (familial) or secondary causes.
Familial HLH is rare, while secondary causes in adults include infection, autoimmunity, and malignancy. HLH in adults tends to be confused with or misdiagnosed as sepsis, mainly due to similar clinical manifestations and laboratory findings, which make it difficult to diagnose HLH rapidly and adopt immunosuppressive agents and/or chemotherapy adequately. Treatment of pediatric HLH using HLH-2004 or multi-agent chemotherapy can be applied in adult patients, although the dose and type of drug need to be adjusted.
It is highly recommended that allogenic hematopoietic stem cell transplantation should be used in patients who become reactivated or are refractory to the initial treatment as soon as possible to improve survival. Future clinical trials are warranted to determine more suitable treatments for adult patients with HLH.

참고문헌 (Reference)

1 Balamuth NJ, "Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis" 29 : 569-573, 2007

2 Yoon HS, "UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis" 95 : 622-626, 2010

3 Yoon JH, "Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy" 104 : 269-276, 2019

4 Henter JI, "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation" 100 : 2367-2373, 2002

5 Jabado N, "Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors" 90 : 4743-4748, 1997

6 Imashuku S, "Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis(EBV-HLH); update 2010" 33 : 35-39, 2011

7 Imashuku S, "Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis(EBV-HLH)in young adults : a report from the HLH study center" 41 : 103-109, 2003

8 신호진, "Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis" 대한의학회 23 (23): 439-444, 2008

9 Gupta A, "The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis" 50 : 192-194, 2008

10 Gansner JM, "The rheumatology/hematology interface : CAPS and MAS diagnosis and management" 2018 : 313-317, 2018

11 Ideguchi H, "Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab" 46 : 1621-1622, 2007

12 Mulay S, "Successful resolution of acute myelogenous leukemia-associated hemophagocytic lymphohistiocytosis with decitabine" 52 : 341-343, 2011

13 Baker KS, "Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation" 89 : 3857-3863, 1997

14 Cooper N, "Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis" 107 : 1233-1236, 2006

15 Belyea B, "Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis" 55 : 754-756, 2010

16 Imashuku S, "Soluble interleukin-2 receptor : a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis" 86 : 4706-4707, 1995

17 Marsh RA, "STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America" 55 : 134-140, 2010

18 Ahmed A, "Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis : an open-label, single-centre, pilot trial" 6 : e630-7, 2019

19 Wang J, "Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis" 105 : e210-2, 2020

20 Imashuku S, "Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis" 19 : 2665-2673, 2001

21 Marsh RA, "Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation" 116 : 5824-5831, 2010

22 Rivière S, "Reactive hemophagocytic syndrome in adults : a retrospective analysis of 162 patients" 127 : 1118-1125, 2014

23 Lin TF, "Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality" 56 : 154-155, 2011

24 Nagafuji K, "Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis" 92 : 978-981, 2007

25 Chen JH, "Pathology of the liver in familial hemophagocytic lymphohistiocytosis" 34 : 852-867, 2010

26 Henter JI, "Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis" 130 : 358-365, 1997

27 Thaunat O, "Nephrotic syndrome associated with hemophagocytic syndrome" 69 : 1892-1898, 2006

28 Ishii E, "Nationwide survey of hemophagocytic lymphohistiocytosis in Japan" 86 : 58-65, 2007

29 Feldmann J, "Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis(FHL3)" 115 : 461-473, 2003

30 Schram AM, "Marked hyperferritinemia does not predict for HLH in the adult population" 125 : 1548-1552, 2015

31 Machaczka M, "Malignancy-associated hemophagocytic lymphohistiocytosis in adults : a retrospective population-based analysis from a single center" 52 : 613-619, 2011

32 Takada H, "Interleukin-18 in hemophagocytic lymphohistiocytosis" 42 : 21-28, 2001

33 Janka G, "Infectionand malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis" 12 : 435-444, 1998

34 Mahlaoui N, "Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins : a single-center retrospective report of 38 patients" 120 : e622-8, 2007

35 Zhang K, "Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH" 118 : 5794-5798, 2011

36 Jordan MB, "How I treat hemophagocytic lymphohistiocytosis" 118 : 4041-4052, 2011

37 Allen CE, "Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis" 50 : 1227-1235, 2008

38 de Kerguenec C, "Hepatic manifestations of hemophagocytic syndrome : a study of 30 cases" 96 : 852-857, 2001

39 Janka GE, "Hemophagocytic syndromes--an update" 28 : 135-142, 2014

40 Karras A, "Hemophagocytic syndrome in renal transplant recipients : report of 17 cases and review of literature" 77 : 238-243, 2004

41 Aricò M, "Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society" 10 : 197-203, 1996

42 Filipovich AH, "Hemophagocytic lymphohistiocytosis(HLH)and related disorders" 127-131, 2009

43 Kögl T, "Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice : T-cell exhaustion limits fatal disease" 121 : 604-613, 2013

44 Meki A, "Hemophagocytic lymphohistiocytosis in chronic lymphocytic leukemia" 29 : e685-e687, 2011

45 Arico M, "Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene" 97 : 1131-1133, 2001

46 Filipovich AH, "Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders" 28 : 293-313, 2008

47 Griffin G, "Hemophagocytic lymphohistiocytosis : an update on pathogenesis, diagnosis, and therapy" 34 : 101515-, 2020

48 Raschke RA, "Hemophagocytic lymphohistiocytosis : a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults" 140 : 933-938, 2011

49 Cesaro S, "Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis : a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology(AIEOP)" 93 : 1694-1701, 2008

50 Horne A, "Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis" 129 : 622-630, 2005

51 Henter J, "HLH-2004 : diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis" 48 : 124-131, 2007

52 Sumegi J, "Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis" 121 : e14-e24, 2013

53 Sumegi J, "Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis" 117 : e151-e160, 2011

54 McCall CM, "Flow cytometric findings in hemophagocytic lymphohistiocytosis" 137 : 786-794, 2012

55 Meeths M, "Familial hemophagocytic lymphohistiocytosis type 3(FHL3)caused by deep intronic mutation and inversion in UNC13D" 118 : 5783-5793, 2011

56 Gholam C, "Familial haemophagocytic lymphohistiocytosis : advances in the genetic basis, diagnosis and management" 163 : 271-283, 2011

57 Gupta AA, "Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution" 31 : 81-84, 2009

58 Chung HJ, "Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis" 32 : 239-247, 2010

59 Jin YK, "Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis : a retrospective study of 78 pediatric cases in mainland of China" 123 : 1426-1430, 2010

60 Buyse S, "Critical care management of patients with hemophagocytic lymphohistiocytosis" 36 : 1695-1702, 2010

61 Lehmberg K, "Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies" 100 : 997-1004, 2015

62 Félix FH, "Cloak and dagger : the case for adult onset still disease and hemophagocytic lymphohistiocytosis" 29 : 973-974, 2009

63 Koh KN, "Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea : report of a nationwide survey from Korea Histiocytosis Working Party" 94 : 51-59, 2015

64 Fukaya S, "Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases : analysis of 30 cases" 47 : 1686-1691, 2008

65 Park HS, "Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma : an analysis of treatment outcome and prognostic factors" 91 : 897-904, 2012

66 Otrock ZK, "Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis" 90 : 220-224, 2015

67 Horne A, "Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis" 143 : 75-83, 2008

68 Egeler RM, "Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis" 18 : 340-345, 1996

69 Tseng YT, "Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults" 44 : 191-197, 2011

70 Henter JI, "Biology and treatment of familial hemophagocytic lymphohistiocytosis : importance of perforin in lymphocytemediated cytotoxicity and triggering of apoptosis" 38 : 305-309, 2002

71 Jordan MB, "An animal model of hemophagocytic lymphohistiocytosis(HLH) : CD8+ T cells and interferon gamma are essential for the disorder" 104 : 735-743, 2004

72 Imashuku S, "Advances in the management of hemophagocytic lymphohistiocytosis" 72 : 1-11, 2000

73 Ramos Casals M, "Adult haemophagocytic syndrome" 383 : 1503-1516, 2014

74 Machaczka M, "Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma" 28 : 539-543, 2011

75 Yoon SE, "A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis : a prospective cohort study" 99 : 2095-2104, 2020